Treatment of intractable ascites with the Denver peritoneovenous shunt was evaluated. Significantly better operative survival and postoperative shunt patency were seen in patients with class B disease when compared with those with class C disease. Postoperative shunt-related complications were common in both groups. Peritoneovenous shunting was not effective in treating patients with hepatorenal syndrome.
ASJC Scopus subject areas